Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on: January 29,2024

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on:January 29,2024

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on: January 29,2024

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on:January 29,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on: January 29,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on:January 29,2024

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on: April 07,2024

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on:April 07,2024

Tumor microbiome linked to immunotherapy success in sarcoma patients

by Stephanie Winn,UC DavisSoft tissue sarcomas intratumoral microbiome at diagnosis may link with prognosis. (A) Representative gross examination of extremity synovial sarcoma specimen; asterisk

Updated on: January 22,2024

Tumor microbiome linked to immunotherapy success in sarcoma patients

by Stephanie Winn,UC DavisSoft tissue sarcomas intratumoral microbiome at diagnosis may link with prognosis. (A) Representative gross examination of extremity synovial sarcoma specimen; asterisk

Updated on:January 22,2024

Newly identified genetic markers classify previously undetermined glioblastoma tumors

by Duke UniversitySMARCAL1 mutations identified in this study were found to be involved in how cancer cells become immortal by keeping their telomeres long through a process known as alternative

Updated on: March 01,2024

Newly identified genetic markers classify previously undetermined glioblastoma tumors

by Duke UniversitySMARCAL1 mutations identified in this study were found to be involved in how cancer cells become immortal by keeping their telomeres long through a process known as alternative

Updated on:March 01,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

byHarvard T.H. Chan School of Public HealthCredit: Pixabay/CC0 Public DomainQuitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new

Updated on: January 30,2024

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

byHarvard T.H. Chan School of Public HealthCredit: Pixabay/CC0 Public DomainQuitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new

Updated on:January 30,2024

Study finds patient messages help predict medication adherence

by Paul Govern,Vanderbilt UniversityCredit: CC0 Public DomainAround two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, wi

Updated on: March 06,2024

Study finds patient messages help predict medication adherence

by Paul Govern,Vanderbilt UniversityCredit: CC0 Public DomainAround two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, wi

Updated on:March 06,2024

Medicare to cover CAR-T therapy for leukemia, lymphoma

A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.Chimeric antigen receptor T-cell (CAR-T)therapyboosts a patient's own immune cells

Updated on: May 17,2024

Medicare to cover CAR-T therapy for leukemia, lymphoma

A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.Chimeric antigen receptor T-cell (CAR-T)therapyboosts a patient's own immune cells

Updated on:May 17,2024

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in

Updated on: January 30,2024

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in

Updated on:January 30,2024

Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates

by Society of Nuclear Medicine and Molecular ImagingSummary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiat

Updated on: January 15,2024

Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates

by Society of Nuclear Medicine and Molecular ImagingSummary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiat

Updated on:January 15,2024